Cargando…

(349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients

PURPOSE: Three SARS-CoV-2-directed anti-viral therapies are currently accessible in the United States: remdesivir (REM), molnupiravir (MOL), and nirmatrelvir+ritonavir. The latter has significant drug-drug interactions and is typically not used in lung transplant recipients (LTRs). We compared the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razia, D., Sindu, D., Grief, K., Cherrier, L., Omar, A., Walia, R., Tokman, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068060/ http://dx.doi.org/10.1016/j.healun.2023.02.1653

Ejemplares similares

Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
por: Sindu, Devika, et al.
Publicado: (2023)

COVID-19 Has a High Mortality Rate in Lung Transplant Recipients: A Large Single-Center Experience
por: Razia, D., et al.
Publicado: (2022)

Outcomes of Critically Ill Lung Transplant Recipients with COVID-19
por: Razia, D., et al.
Publicado: (2022)

(700) Vaccination with >2 Doses of Mrna Vaccines is Needed to Reduce Mortality Among Lung Transplant Recipients with Covid-19
por: Sindu, D., et al.
Publicado: (2023)

(698) Covid-19 is Less Severe with the Omicron Variant Compared to Prior Variants and the Original Sars-Cov-2 Strain in Lung Transplant Recipients
por: Sindu, D., et al.
Publicado: (2023)

Hospitalized patients with irreversible lung injury from COVID-19 have higher morbidity but similar 1-year survival after lung transplant compared to hospitalized patients transplanted for restrictive lung disease
por: Razia, Deepika, et al.
Publicado: (2023)

(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
por: Sindu, D., et al.
Publicado: (2023)

A Comparison of Short-Term Morbidity and Mortality Among Inpatient Lung Transplant Recipients Transplanted for COVID-19 and Other Restrictive Lung Diseases
por: Razia, D., et al.
Publicado: (2022)

Lung Transplantation for COVID-19-Induced Respiratory Failure: Single-Center Case Series
por: Razia, D., et al.
Publicado: (2022)

Obese Lung Recipients May Be Susceptible to Severe COVID-19 Outcomes Compared to Controls
por: Razia, D., et al.
Publicado: (2022)

Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
por: Tokman, Sofya, et al.
Publicado: (2016)

Two Cases of Spontaneous Bleeding in Lung Transplant Recipients Treated with Systemic Anticoagulation for COVID-19
por: Olson, M.T., et al.
Publicado: (2021)

Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series
por: Banks, Paul N., et al.
Publicado: (2018)

Antibody-Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient
por: Arjuna, Ashwini, et al.
Publicado: (2021)

Efficacy of low-dose valganciclovir in CMV R+ lung transplant recipients: a retrospective comparative analysis
por: Hunt, Jessica, et al.
Publicado: (2021)

Remdesivir resistance in transplant recipients with persistent COVID-19
por: Hogan, John I, et al.
Publicado: (2022)

PROLONGED COLONIZATION AND COISOLATION OF SARS-COV-2 IN UNVACCINATED RECIPIENTS OF LUNG TRANSPLANTS
por: RAZIA, DEEPIKA, et al.
Publicado: (2022)

Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable
por: Razia, Deepika, et al.
Publicado: (2022)

SARS-CoV-2 Re-Infection in a Lung Transplant Recipient
por: Buddhdev, B., et al.
Publicado: (2021)

Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
por: Buxeda, Anna, et al.
Publicado: (2021)

Lung Transplant Candidates With Pretransplant Gastroesophageal Reflux and Antibodies to Lung Self-antigens Have Shorter CLAD-free Survival After Transplant
por: Razia, Deepika, et al.
Publicado: (2022)

EXCELLENT ALLOGRAFT RECOVERY DESPITE PROLONGED SARS-COV-2 SHEDDING AFTER REDUCTION OF IMMUNOSUPPRESSION IN LUNG TRANSPLANT RECIPIENT
por: RAZIA, DEEPIKA, et al.
Publicado: (2021)

Effect of pirfenidone on wound healing in lung transplant patients
por: Mortensen, Amber, et al.
Publicado: (2018)

Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir
por: Jemth, Ann-Sofie, et al.
Publicado: (2022)

Persistent Subclinical SARS-CoV-2 Isolation After Redo Lung Transplant for COVID-19-Induced Lung Injury
por: Razia, D., et al.
Publicado: (2022)

Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19
por: Lê, Minh Patrick, et al.
Publicado: (2020)

Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection
por: Habeeb, Ehsan, et al.
Publicado: (2023)

Orthostatic Hypotension and Concurrent Autonomic Dysfunction: A Novel Complication of Lung Transplantation
por: Razia, Deepika, et al.
Publicado: (2022)

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients
por: Poznański, Paweł, et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Health Tract No. 349: Healthful Atmosphere
Publicado: (1868)

Remdesivir in Solid Organ Recipients for COVID-19 Pneumonia
por: Fesu, Dorottya, et al.
Publicado: (2022)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

349. Implementation of a Multidisciplinary HIV-Pulmonary Clinic
por: Sellers, Subhashini A, et al.
Publicado: (2019)

Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
por: Olson, M.T., et al.
Publicado: (2022)

MD 349: Impedance Localization with AC-dipole
por: Biancacci, Nicolo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cp5jeqhm38e7tukjkspl1tqag9